Home › Funds › Ranger Investment Management, L.P. › HALO
Ranger Investment Management, L.P. position in HALO
HALOZYME THERAPEUTICS INC · Health Care
Ranger Investment Management, L.P. reported holding 99,888 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$11.0M, representing 1.03% of its reported portfolio and ranking #39 among its reported holdings. Ranger Investment Management, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Ranger Investment Management, L.P.'s HALO position evolved
Ranger Investment Management, L.P. first disclosed a stake in HALO in Q3 2026 at 99,888 shares (US$11.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 99.89K | $11.03M | New |
About HALO and 13F data
HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$178.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HALO
- CONGRESS ASSET MANAGEMENT CO 2.28M sh · $251.89M · Q3 2026
- SNYDER CAPITAL MANAGEMENT L P 2.40M sh · $187.54M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.62M sh · $178.46M · Q3 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 1.58M sh · $174.27M · Q3 2026
- Stephens Investment Management Group LLC 1.41M sh · $156.00M · Q3 2026
- GW&K Investment Management, LLC 1.14M sh · $125.86M · Q3 2026
- WASATCH ADVISORS LP 1.05M sh · $115.88M · Q3 2026
- Boston Trust Walden Corp 1.04M sh · $114.35M · Q3 2026
- LMR Partners LLP 45.00M sh · $65.81M · Q2 2026
More on Ranger Investment Management, L.P.
FAQ
How long has Ranger Investment Management, L.P. held HALO?
Ranger Investment Management, L.P. has disclosed HALO holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Ranger Investment Management, L.P.'s current position in HALO?
As of Q3 2026, Ranger Investment Management, L.P. holds 99.89K shares of HALO (HALOZYME THERAPEUTICS INC), valued at $11.03M, representing 1.03% of its reported portfolio and ranking #39.
Has Ranger Investment Management, L.P. been buying or selling HALO?
In the latest 13F filing (Q3 2026), Ranger Investment Management, L.P. newly opened its position in HALO.
Which other funds hold HALO?
Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, SNYDER CAPITAL MANAGEMENT L P, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.